Saige-Dx
by DeepHealth, Inc. 3 variants
510(k) K220105
Saige-Dx is a medical device (FDA Class II; FDA product code QDQ) made by DeepHealth, Inc., cleared under FDA 510(k) K220105 on 12 May 2022, active as of 10 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK220105 | Date12 May 2022 | StatusActive |
Official records
- FDA 510(k) database K220105
From the FDA record
- Received by the FDA
- 12 Jan 2022
- FDA decision
- 12 May 2022 (Substantially Equivalent)
- FDA review time
- 120 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QDQ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2090
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).
- Lunit Insight MMG (v1.1.10) by Lunit Inc.
- Genius AI Detection 2.0 by Hologic, Inc.
- See-Mode Augmented Reporting Tool by SEE-MODE TECHNOLOGIES PTY LTD
- Prostate MR AI (VA10A) by Siemens Healthcare GmbH
- ProFound AI Software V2.1 by Icad, Inc.
- ProFound Detection (V4.0) by Icad, Inc.
- ProstatID by SCANMED, LLC
- Lunit INSIGHT DBT (V1.2) by Lunit Inc.
- Transpara 1.7.2 by Screenpoint Medical B.V.
- Transpara (2.1.0) by Screenpoint Medical B.V.